Adriaan C. Jöbsis

Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome

Bas W.G. van Rhijn, André N. Vis, Theodorus van der Kwast et al. · Journal of Clinical Oncology · 2003 · 321 citations

Medicine, Oncology, Pathology +15

<b> <i>FGFR3</i> </b> and <b> <i>P53</i> </b> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Bas W.G. van Rhijn, Theodorus van der Kwast, André N. Vis et al. · Cancer Research · 2004 · 223 citations · Full text

Medicine, Genetics, Oncology +11

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, André N. Vis et al. · European Urology · 2010 · 193 citations

Medicine, Oncology, Urology +14

Frequent <i>FGFR3</i> mutations in urothelial papilloma

Bas W.G. van Rhijn, Rodolfo Montironi, Ellen C. Zwarthoff et al. · The Journal of Pathology · 2002 · 189 citations

Medicine, Molecular Genetics, Oncology +12

The Pathologist’s Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading

Bas W.G. van Rhijn, Geert J.L.H. van Leenders, Bert C.M. Ooms et al. · European Urology · 2009 · 82 citations

Medicine, Oncology, Pathology +12